(Q34555477)

3 August 2017

title

Discovery of serum protein biomarkers in the mdx mouse model and cross-species comparison to Duchenne muscular dystrophy patients (English)

1 reference

Duchenne muscular dystrophy

3 August 2017

0 references

0 references

1 reference

1 reference

Luca Bello

9

0 references

Craig M. McDonald

object named as

Craig McDonald

16

0 references

Kanneboyina Nagaraju

10

object named as

Kanneboyina Nagaraju

1 reference

3 August 2017

Heather Gordish-Dressman

7

object named as

Heather Gordish-Dressman

1 reference

3 August 2017

12

Eric P Hoffman

1 reference

3 August 2017

Yetrib Hathout

1

1 reference

3 August 2017

Ramya L Marathi

2

1 reference

3 August 2017

Sree Rayavarapu

3

1 reference

3 August 2017

Aiping Zhang

4

1 reference

3 August 2017

Kristy J Brown

5

1 reference

3 August 2017

Haeri Seol

6

1 reference

3 August 2017

Sebahattin Cirak

8

1 reference

3 August 2017

Terry Partridge

11

1 reference

3 August 2017

Shin'ichi Takeda

13

1 reference

3 August 2017

Jean K Mah

14

1 reference

3 August 2017

Erik Henricson

15

1 reference

3 August 2017

publication date

15 July 2014

1 reference

3 August 2017

published in

Human Molecular Genetics

1 reference

3 August 2017

volume

23

1 reference

3 August 2017

issue

24

1 reference

3 August 2017

page(s)

6458-6469

1 reference

New developments in the use of gene therapy to treat Duchenne muscular dystrophy

3 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4240201

Dystromirs as serum biomarkers for monitoring the disease severity in Duchenne muscular Dystrophy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4240201

VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4240201

Matrix metalloproteinase-9 inhibition improves proliferation and engraftment of myogenic cells in dystrophic muscle of mdx mice

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4240201

Comparative proteomic profiling of soleus, extensor digitorum longus, flexor digitorum brevis and interosseus muscles from the mdx mouse model of Duchenne muscular dystrophy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4240201

Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4240201

Proteomic identification of biomarkers of skeletal muscle disorders.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4240201

Dystrophin deficiency leads to disturbance of LAMP1-vesicle-associated protein secretion

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4240201

Identification of disease specific pathways using in vivo SILAC proteomics in dystrophin deficient mdx mouse.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4240201

The Canadian experience with long-term deflazacort treatment in Duchenne muscular dystrophy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4240201

Gene therapy for muscular dystrophy: lessons learned and path forward

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4240201

Amelioration of Duchenne muscular dystrophy in mdx mice by elimination of matrix-associated fibrin-driven inflammation coupled to the αMβ2 leukocyte integrin receptor

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4240201

Thrombospondin-4 regulates fibrosis and remodeling of the myocardium in response to pressure overload

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4240201

Fibrinogen as a key regulator of inflammation in disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4240201

Impending therapies for Duchenne muscular dystrophy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4240201

Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4240201

Randomized, blinded trial of weekend vs daily prednisone in Duchenne muscular dystrophy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4240201

Serum matrix metalloproteinase-9 (MMP-9) as a biomarker for monitoring disease progression in Duchenne muscular dystrophy (DMD).

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4240201

Identification of muscle-specific microRNAs in serum of muscular dystrophy animal models: promising novel blood-based markers for muscular dystrophy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4240201

Current status of pharmaceutical and genetic therapeutic approaches to treat DMD.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4240201

Systemic administration of PRO051 in Duchenne's muscular dystrophy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4240201

miRNAs as serum biomarkers for Duchenne muscular dystrophy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4240201

Differential proteomic analysis of mammalian tissues using SILAM.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4240201

Read-through strategies for suppression of nonsense mutations in Duchenne/ Becker muscular dystrophy: aminoglycosides and ataluren (PTC124).

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4240201

Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4240201

Emerging genetic therapies to treat Duchenne muscular dystrophy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4240201

Reliability of the North Star Ambulatory Assessment in a multicentric setting.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4240201

Update on the management of Duchenne muscular dystrophy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4240201

Serum protein profiling in mice: identification of Factor XIIIa as a potential biomarker for muscular dystrophy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4240201

Glucocorticoid corticosteroids for Duchenne muscular dystrophy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4240201

Myomesin 3, a novel structural component of the M-band in striated muscle

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4240201

The role of the novel adipocyte-derived hormone adiponectin in human disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4240201

Malate dehydrogenases--structure and function

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4240201

Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4240201

Mechanisms of resistance to pathogenesis in muscular dystrophies

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4240201

Structural and ultrastructural changes in the skeletal muscles of patients in the early stages of Duchenne muscular dystrophy and "possible" carriers

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4240201

Duchenne muscular dystrophy. A population study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4240201

The substrate specificity and regulation of the protein phosphatases involved in the control of glycogen metabolism in mammalian skeletal muscle

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4240201

Targeted exon skipping as a potential gene correction therapy for Duchenne muscular dystrophy.

7 July 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU366

Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU366

Eteplirsen for the treatment of Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU366

The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU366

Coagulation and fibrinolysis disorder in muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU366

Proteomic profile of differentially expressed plasma proteins from dystrophic mice and following suberoylanilide hydroxamic acid treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU366

Developmental regulation and cellular distribution of human cytosolic malate dehydrogenase (MDH1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU366

Filamin C plays an essential role in the maintenance of the structural integrity of cardiac and skeletal muscles, revealed by the medaka mutant zacro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU366

Proteomics profiling of urine reveals specific titin fragments as biomarkers of Duchenne muscular dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU366

Targeted disruption of exon 52 in the mouse dystrophin gene induced muscle degeneration similar to that observed in Duchenne muscular dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU366

Fibronectin is a serum biomarker for Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU366

Time course of changes in plasma membrane permeability in the dystrophin-deficient mdx mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU366

Serum creatine phosphokinase. Activity in progressive muscular dystrophy and neuromuscular diseases

21 January 2018

1 reference

12 December 2020

Studies of enzymes in serum in muscular dystrophy. II. Diagnostic and prognostic significance in relatives of dystrophic persons

1 reference

12 December 2020

Serum myoglobin in muscular dystrophy and carrier detection

1 reference

12 December 2020

Long-term benefits and adverse effects of intermittent versus daily glucocorticoids in boys with Duchenne muscular dystrophy

1 reference

12 December 2020

Magnetic resonance imaging in Duchenne muscular dystrophy: longitudinal assessment of natural history over 18 months

1 reference

12 December 2020

Plasma phosphoglycerate mutase as a marker of muscular dystrophy

1 reference

12 December 2020

Prednisone treatment in Duchenne muscular dystrophy. Long-term benefit

1 reference

12 December 2020

Ultrastructure of the skeletal muscle in the X chromosome-linked dystrophic (mdx) mouse. Comparison with Duchenne muscular dystrophy

1 reference

12 December 2020

Degradation of connectin (titin) in Fukuyama type congenital muscular dystrophy: immunochemical study with monoclonal antibodies

1 reference

12 December 2020

Carbonic anhydrase III in serum in muscular dystrophy and other neurological disorders: relationship with creatine kinase

1 reference

12 December 2020

Prednisone in Duchenne dystrophy. A randomized, controlled trial defining the time course and dose response. Clinical Investigation of Duchenne Dystrophy Group

1 reference

12 December 2020

Deflazacort in Duchenne dystrophy: study of long-term effect

1 reference

12 December 2020

Early onset of inflammation and later involvement of TGFbeta in Duchenne muscular dystrophy

1 reference

12 December 2020

Cardiac troponin I for accurate evaluation of cardiac status in myopathic patients

1 reference

12 December 2020

Development of a functional assessment scale for ambulatory boys with Duchenne muscular dystrophy

1 reference

12 December 2020

Identifiers

DOI

10.1093/HMG/DDU366

1 reference

3 August 2017

1 reference

3 August 2017

1 reference